Asclepes Research Centers,PC — research payments reported

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$9,590	1
2023	Research	$24,338	3
2022	Research	$25,029	9
2021	Research	$30,810	10
2020	Research	$49,740	13
2019	Research	$11,400	3

Breakdown

Who paid Research payments · program years 2019–2024

Sanofi Pasteur Inc. $108,400 33 payments
Sanofi US Services Inc. $42,507 6 payments

Studies the money was for Research payments · program years 2019–2024

MET42 Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers $87,355 25 payments
Ph3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study With Open Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) $42,507 6 payments
A Phase III, Partially Modified Double-blind, Randomized, Parallel-group, Active-controlled, Multi-center Study to Compare the Immunogenicity and Describe the Safety of MenACYW Conjugate Vaccine and MENVEO When Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in the United States $21,045 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.